Dr. Jill Crista and Dr. Neil Nathan, leading experts at the forefront of mold-related illness diagnosis and treatment, have teamed up to advance mold research.
Phase 1 is complete!
We are deeply grateful to everyone who participated and generously shared their information. This research would not be possible without your contributions.
Mold IQ Research Initiative
The Mold Illness Questionnaire (MoldIQ) Research Initiative is based on Dr. Jill’s clinical diagnostic questionnaire, which continues to be her go-to diagnostic questionnaire to discover mold-related illness.
Want to get updates?
Mold is a common underlying cause of complex, chronic illnesses, yet research is lacking.
Current update
The purpose of this phase was to validate the questionnaire by gathering meaningful clinical data on mold-related illness, with the goal of publishing results in peer-reviewed journals and advancing building policy changes. Initial results indicate that the questionnaire can accurately flag individuals at risk, making it a useful tool for both research and clinical care.
We’re pleased to share that this research is on target and already generating interest from a university partner. Together with this partner, we are further refining the questionnaire and developing interventional clinical trials to explore effective treatments aimed at reducing suffering from indoor mold exposure.
Be part of our global initiative to stop mold in its tracks.
Research in humans is lacking!
Since mold and mycotoxins are known health hazards, medical ethics rules say that we can’t purposefully expose you to these poisons in a research study, only to figure out how to get you better. We simply aren’t allowed to do that research. (Thank goodness!) Besides, the first rule of treatment is to remove you from the exposure in the first place.
We rely on people like you who are already affected.
The purpose of this research is to gather meaningful clinical data regarding mold-related illness by people who have unfortunately already been exposed. Our goal is to publish the findings in peer-reviewed medical journals. This research has the potential to inform the design of future studies, with a focus on developing accepted treatments.





